QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

	Help viewing high resolution images
	Return to article

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Simplified version of the phosphatidylinositol cycle. Inositol is obtained from nutritional sources or de novo synthesis (not shown) or it is recovered from inositol trisphosphate [Ins(1,4,5)P₃] by a salvage pathway that involves sequential dephosphorylation of inositol phosphates by the enzymes inositol polyphosphate phosphatase (IPPase; indicated as step 1) and inositol monophosphate phosphatase (IMPase; step 2), both of which are inhibited by lithium. Phosphatidylinositol (PtdIns) is synthesized from inositol and CDP-diacyglycerol (CDP-DAG). Phosphatidylinositol is monophosphorylated to form PtdIns(4)P by type III PtdIns 4-kinase (step 3), which is inhibited by wortmannin (WT) and LY294002 (LY). PtdIns(4)P is phosphorylated by PtdIns(4)P 5-kinase to form phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P₂]. This in turn, is hydrolyzed by phospholipase C (PLC; step 4) to form Ins(1,4,5)P₃ and DAG in a reaction inhibited by U73122. DAG is then converted to phosphatidic acid (PA) and then CDP-DAG to complete the cycle. Note that WT and LY also inhibit PtdIns 3-kinase (not shown) and that a second type of PtdIns 4-kinase, the type II enzyme, is not inhibited by WT or LY.

Return to article